Who created Vyvanse?

Vyvanse was developed by Shire Pharmaceuticals, a biopharmaceutical company. It was approved by the U.S. Food and Drug Administration (FDA) in 2007 for the treatment of attention-deficit/hyperactivity disorder (ADHD). The active ingredient in Vyvanse is lisdexamfetamine, which is a prodrug that becomes active only after being metabolized in the body.